A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT).
Charlotte I StroesSandor SchokkerMohammed KhurshedStephanie O van der WoudeRon Aa MathôtMarije SlingerlandJudith de Vos-GeelenMassimo ZucchettiCristina MatteoErik van DijkBauke YlstraVictor ThijssenSarah DerksTesfay GodefaWillemieke DijksterhuisGerben E BreimerOtto M van DeldenRob Ha VerhoevenSybren L MeijerMaarten F BijlsmaHanneke W M van LaarhovenPublished in: Therapeutic advances in medical oncology (2022)
Clinicaltrials.gov, NCT02406170, https://clinicaltrials.gov/ct2/show/NCT02406170.